skip to Main Content

Disparities in Stage-Specific Guideline-Concordant Cancer-Directed Treatment for Patients with Pancreatic Adenocarcinoma

Newsfeed image, light gray text on dark gray background
The utilization of cancer-directed treatment for patients with all stages of pancreatic cancer in the USA is unknown.

This study sought to examine national practice patterns and identify patient, hospital, regional, and other factors associated with disparities in the use of guideline-concordant cancer-directed therapy. Read more . . . 

Back To Top